Інформація опублікована з довідковою метою і не є рекламою, офертою, публічною пропозицією або керівництвом до застосування. Представлена виключно для інформування наших пацієнтів, які перебувають за кордоном. Сайт не здійснює жодної дистанційної торгівлі. Продаж, розповсюдження, доставка та призначення товарів через веб-ресурс не провадяться. Застосування товарів та медичних послуг можливе виключно за призначенням лікаря. Консультації надаються фахівцями клініки у очному форматі або за допомогою дистанційної медичної консультації у рамках чинного законодавства. Прошу звернути Вашу увагу, що у цьому довіднику продаж товарів програмно не передбачено.
Tests for urogenital infections
Tests for urogenital infections
We perform laboratory diagnostics for urogenital infections and microbiocenosis disorders in both women and men. Separate tests and ready-made panels are available for screening and diagnosis clarification.
Available tests include:
- Smear microscopy: purity level, increased leukocytes, decreased lactobacilli, presence of aerobic, intestinal bacteria, fungi, protozoa, etc.
- Bacterial culture of vaginal/urethral discharge (gram-positive and gram-negative), determination of antibiotic sensitivity.
- PCR tests:
- UNIFLOR SCREEN
- Neisseria gonorrhoeae (gonorrhea);
- Chlamydia trachomatis (urogenital chlamydia);
- Trichomonas vaginalis (trichomoniasis);
- Mycoplasma genitalium (genital mycoplasmosis).
- Opportunistic bacteria and fungi that may indicate dysbiotic changes and cause infectious-inflammatory diseases of the genital organs:
- Gardnerella vaginalis (anaerobic vaginitis, bacterial vaginosis);
- Candida albicans (candidiasis);
- Mycoplasma hominis (mycoplasmosis);
- Ureaplasma urealyticum (ureaplasmosis);
- Ureaplasma parvum (ureaplasmosis).
- HPV PCR test for determining types of human papillomavirus (HPV): high oncogenic (carcinogenic) risk – 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68; low oncogenic risk – 6, 11, 40, 42, 43, 44, 54, 61, 70), DNA (semi-quantitative determination).
Additionally, upon request: screening for syphilis, HIV, hepatitis B and C as part of an extended examination.
Enzyme-linked immunosorbent assay (ELISA), which detects either antibodies (IgG, IgM, IgA) to pathogens or their antigens:
- Chlamydia trachomatis: IgG, IgM, IgA
- Mycoplasma hominis: IgM, IgG
- Ureaplasma urealyticum: IgA, IgG
- Trichomonas vaginalis: IgG, IgM, IgA
- Herpes simplex virus (HSV 1/2): IgG, IgM
- And others.
The final interpretation of results and the need for treatment are determined by a doctor considering symptoms and medical history. Detection of opportunistic microorganisms (e.g., Ureaplasma, M. hominis) without complaints does not always require therapy. Partners are recommended to undergo simultaneous examination/treatment if STIs are detected; abstinence or barrier protection is advised until treatment is completed. Follow-up tests are conducted as prescribed by a doctor within specified timeframes.
Contact us to select the appropriate set of tests and a convenient time for testing. We will help quickly and accurately identify the causes of symptoms and maintain reproductive health.
Available tests include:
- Smear microscopy: purity level, increased leukocytes, decreased lactobacilli, presence of aerobic, intestinal bacteria, fungi, protozoa, etc.
- Bacterial culture of vaginal/urethral discharge (gram-positive and gram-negative), determination of antibiotic sensitivity.
- PCR tests:
- UNIFLOR SCREEN
- Neisseria gonorrhoeae (gonorrhea);
- Chlamydia trachomatis (urogenital chlamydia);
- Trichomonas vaginalis (trichomoniasis);
- Mycoplasma genitalium (genital mycoplasmosis).
- Opportunistic bacteria and fungi that may indicate dysbiotic changes and cause infectious-inflammatory diseases of the genital organs:
- Gardnerella vaginalis (anaerobic vaginitis, bacterial vaginosis);
- Candida albicans (candidiasis);
- Mycoplasma hominis (mycoplasmosis);
- Ureaplasma urealyticum (ureaplasmosis);
- Ureaplasma parvum (ureaplasmosis).
- HPV PCR test for determining types of human papillomavirus (HPV): high oncogenic (carcinogenic) risk – 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68; low oncogenic risk – 6, 11, 40, 42, 43, 44, 54, 61, 70), DNA (semi-quantitative determination).
Additionally, upon request: screening for syphilis, HIV, hepatitis B and C as part of an extended examination.
Enzyme-linked immunosorbent assay (ELISA), which detects either antibodies (IgG, IgM, IgA) to pathogens or their antigens:
- Chlamydia trachomatis: IgG, IgM, IgA
- Mycoplasma hominis: IgM, IgG
- Ureaplasma urealyticum: IgA, IgG
- Trichomonas vaginalis: IgG, IgM, IgA
- Herpes simplex virus (HSV 1/2): IgG, IgM
- And others.
The final interpretation of results and the need for treatment are determined by a doctor considering symptoms and medical history. Detection of opportunistic microorganisms (e.g., Ureaplasma, M. hominis) without complaints does not always require therapy. Partners are recommended to undergo simultaneous examination/treatment if STIs are detected; abstinence or barrier protection is advised until treatment is completed. Follow-up tests are conducted as prescribed by a doctor within specified timeframes.
Contact us to select the appropriate set of tests and a convenient time for testing. We will help quickly and accurately identify the causes of symptoms and maintain reproductive health.
